Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA-seq of glioma patient tissues treated by DMSO or LY2109761

ABSTRACT: miRNA-seq of glioma patient tissues treated by DMSO or LY2109761

PROVIDER: PRJNA437874 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6825154.fastq.gz	Fastqsanger.gz
	SRR6825155.fastq.gz	Fastqsanger.gz
	SRR6825156.fastq.gz	Fastqsanger.gz
	SRR6825157.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

miRNA-seq of glioma patient tissues treated by DMSO or LY2109761

Project description:Glioma tissues from patients were cultured in complete DMEM and treated with either DMSO or LY2109761, an inhibitor of TGFBR2. Tissue blocks of TBD0207 and TBD0220 were subjected to miRNA-seq.

2021-03-07 | GSE111675 | GEO

RNA-seq of glioma patient tissues treated by DMSO or LY2109761

Project description:RNA-seq of glioma patient tissues treated by DMSO or LY2109761

| PRJNA437873 | ENA

RNA-seq of glioma patient tissues treated by DMSO or LY2109761

2021-03-07 | GSE111674 | GEO

RNA-seq of glioma patient-derived xenografts treated by DMSO or LY2109761

Project description:RNA-seq of glioma patient-derived xenografts treated by DMSO or LY2109761

| PRJNA437856 | ENA

Gene expression of patient derived xenograft glioblastoma treated with DMSO control or Panobinostat.

Project description:Panobinostat is a non-selective histone deactylase inhibitor which has been approved by FDA for treatment of mutiple myeloma. Whether and how the drug works on glioblastoma remains unclear. Here we treated mice implanted with patient derived xenograft glioblastoma G43 with DMSO or Panobinostat and harvest the tumors for microarray analysis for gene expression results.

2019-01-09 | GSE108957 | GEO

RNA-seq of glioma patient-derived xenografts treated by DMSO or LY2109761

Project description:We employed the patient-derived xenografts (PDX) model to test the efficiency of LY2109761 in vivo. The drug was intraperitoneally administered, and the mice were sacrificed on the 31st day. The tumors were excised and subjected to RNA-seq. All groups had similar expression density distributions. Hierarchical clustering showed that the same processing groups had the closest distances.

2021-03-07 | GSE111673 | GEO

Expression data from human glioma tissues

Project description:Gliomas are aggressive lethal solid brain tumors arising from support cells in the central nervous system. Despite intense efforts to optimize the treatment of gliomas, the outcomes of high grade glioma patients are still frustrating. The causes and progress of gliomas have been investigated extensively; however, the genetic factors involved in the development of this disease remain poorly understood. We used microarrays to detail the global program of gene expression in different grade glioma tissues and try to find out some genes associated with the tumorigenesis of gliomas. Grade I to grade IV glioma tissues were selected in surgical operations for RNA extraction and hybridization on Affymetrix microarrays. We sought to obtain gene expression profiles. To that end, we hand-selected several genes that were differentially expressed in different grade glioma tissues and then performed a further study to identify the role of these genes in the process of the development of gliomas.

2013-04-10 | E-GEOD-45921 | biostudies-arrayexpress

miRNA expression profile in hepatocellular carcinoma patient paired tissues

Project description:miRNA expression profile in hepatocellular carcinoma patient paired tissues

| PRJNA656760 | ENA

Analysis of microRNA expression profile in malignant glioma tissues

Project description:Malignant gliomas represent the most devastating group of brain tumors in adults, among which glioblastoma multiforme (GBM) exhibits the highest malignancy rate. Despite combined modality treatment, GBM recurs and is invariably fatal. A further insight into molecular background of gliomagenesis is required to improve patient outcome. The first aim of this study was to gain broad information on miRNA expression pattern in malignant gliomas, mainly GBM. We investigated the global miRNA profile of malignant glioma tissues by means of miRNA microarrays, deep sequencing and meta-analysis. We selected miRNAs the most frequently deregulated in glioblastoma tissues as well as peritumoral brain areas in comparison to normal human brain. We found candidate miRNAs contributing to progression from gliomas grade III to gliomas grade IV. The meta-analysis of miRNA profiling studies in GBM tissues summarizes the past and recent advances in an investigation of miRNA signature in GBM versus noncancerous human brain and provides a comprehensive overview. We proposed a set of 35 miRNAs which expression is the most frequently deregulated in GBM patients and 30 miRNA candidates recognized as novel GBM biomarkers. miRNA expression profile in the adult malignant gliomas, glioma peritumoral tissues and normal human brain.

2014-09-26 | E-GEOD-61710 | biostudies-arrayexpress

Expression data from glioma patient

Project description:Multicentric lesions constitute an increasingly diagnosed subgroup of glioblastoma (GBM) and are more malignant than that of solitary GBM. Understanding their biology is necessary and urgent for glioma patient treatment. However, molecular basis of these lesions are poorly characterized. We used microarrays to determine the gene expression profiling of three lesions from one multicentric GBM.

2019-03-31 | GSE79772 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data